Diagnostic imaging service provider Lumexa Imaging (LMRI.US) plans to price its IPO at $17-20 per share, aiming to raise $463 million.

American outpatient imaging diagnostic service provider Lumexa Imaging Holdings announced the terms of its initial public offering (IPO) on Tuesday. The company plans to issue 25 million shares of stock at a price of $17-20 per share to raise $463 million. The company plans to list on the Nasdaq under the ticker symbol "LMRI". Based in North Carolina, Lumexa Imaging is a national provider of outpatient diagnostic imaging services, operating 184 centers in 13 states through wholly owned operations and joint ventures with healthcare systems. The company offers a range of advanced and routine imaging services including magnetic resonance imaging (MRI), computerized tomography (CT), positron emission tomography (PET), X-rays, ultrasound, and mammography. Founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, the company started with 20 centers and expanded through 20 acquisitions and the opening of 41 new stores. Currently, the company has built a diversified referral network, with collaborating physicians covering over 29,000 healthcare facilities and a total of around 100,000 individuals. Data shows that the company had sales of $1 billion in the 12 months ending September 30, 2025.